Erzofri extended-release (Paliperidone Palmitate): Uses, Side Effects & Interactions
1. Introduction and Mechanism of Action for Erzofri Erzofri extended-release is a long-acting injectable atypical antipsychotic containing the active ingredient paliperidone palmitate, utilized heavily for the acute and maintenance treatment of schizophrenia and schizoaffective disorder. The most prominent side effects include pronounced extrapyramidal symptoms, significant weight gain, extreme hyperprolactinemia, and severe localized injection site pain. … Read more